IL-8(3–73)K11R Is a High Affinity Agonist of the Neutrophil CXCR1 and CXCR2

This publication has 18 references indexed in Scilit:

• Lymphotactin Expression by Engineered Myeloma Cells Drives Tumor Regression: Mediation by CD4+ and CD8+ T Cells and Neutrophils Expressing XCR1 Receptor
  The Journal of Immunology, 2001
• Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines
  Arthritis & Rheumatism, 2000
• Production and functional characterization of recombinant bovine interleukin-8 as a specific neutrophil activator and chemoattractant
  Veterinary Immunology and Immunopathology, 1999
• Differential usage of the CXC chemokine receptors 1 and 2 by interleukin‐8, granulocyte chemotactic protein‐2 and epithelial‐cell‐derived neutrophil attractant‐78
  European Journal of Biochemistry, 1998
• Blocking Chemokine Receptors
  The Journal of Experimental Medicine, 1997
• Chemokine Antagonists That Discriminate between Interleukin-8 Receptors
  Journal of Biological Chemistry, 1997
• Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome.
  American Journal of Respiratory and Critical Care Medicine, 1996
• The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor
  Journal of Biological Chemistry, 1996
• Molecular cloning and expression of bovine interleukin-8
  Microbial Pathogenesis, 1996
• Both interleukin‐8 receptors independently mediate chemotaxis
  FEBS Letters, 1994